Elephas logo

Elephas

Live tumor profiling for immunotherapy response prediction

145 employees · est. 2020 · Madison, United States

VS
Orakl Oncology logo

Orakl Oncology

Biology x AI-powered drug development platform to transform precision oncology.

16 employees · est. 2023 · Paris, France

Elephas is the older company (2020 vs 2023); Elephas is the larger of the two.

Side-by-Side Comparison

Elephas Orakl Oncology
Founded
2020 older 2023
Headquarters
Madison, United States Paris, France
Employees
145 larger 16
Industry
AI, Biotechnology, Health Care Not tracked yet
Funding Stage
Series C Seed
Total Funding
$178.50M $14.00M
Funding Rounds
6 2
Services
Elephas Live Platform, Immunotherapy Response Prediction, Functional Testing of Live Tissue, Data Aggregation and Analysis Not tracked yet
Target Customers
Pathology Labs, Healthcare Providers, Cancer Researchers, Biotechnology Companies Not tracked yet
Taxonomy
Ex-vivo Platform, Tumor Profiling, Immunotherapy Response Prediction, Live Patient Biopsies, Tumor Microenvironment, Tumor Heterogeneity, Real-time Immune Characterization, Oncology Diagnostics, Patient-centric Solutions, Cancer Biology, Multimodal Microscopy, Clinical Decision-making, Drug Development, Oncology Innovation Oncology Drug Development, Biological Data Integration, Patient Tumor Avatars, Clinical Data Analysis, Cancer Therapeutics, Target Identification, Pharmaceutical Partnerships
Website
elephas.com orakl-oncology.com
Elephas logo

About Elephas

Elephas, founded in 2020 and headquartered in the United States, is making significant strides in the intersection of AI, Biotechnology, and Health Care. The company's slogan, "Live tumor profiling for immunotherapy response prediction," highlights its core innovation: an ex-vivo platform that analy...

Orakl Oncology logo

About Orakl Oncology

Orakl Oncology, founded in 2023 and headquartered in France, is a pioneering company in the field of oncology drug development. Their slogan, "Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development," reflects their core focus. The compan...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Elephas and Orakl Oncology — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Elephas and Orakl Oncology — by email.

Frequently Asked Questions

Elephas — Live tumor profiling for immunotherapy response prediction. Orakl Oncology — Biology x AI-powered drug development platform to transform precision oncology.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Elephas has raised $178.50M while Orakl Oncology has raised $14.00M.
Elephas and Orakl Oncology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Elephas with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy